Top

Breast Cancer

Published in:

01-04-2004 | Review Article

Present role and future perspectives of the evaluation of the effect of primary chemotherapy by breast imaging

Author: Seigo Nakamura

Published in: Breast Cancer | Issue 2/2004

Title: Present role and future perspectives of the evaluation of the effect of primary chemotherapy by breast imaging
Author: Seigo Nakamura
Publication date: 01-04-2004
Publisher: Springer-Verlag
Published in: Breast Cancer / Issue 2/2004
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.1007/BF02968292

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2004

A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group

Novel sensitizing agents: Potential Contribution of COX-2 inhibitor for endocrine therapy of breast cancer

Sensitization of chemotherapy by anti-HER

Clinical and pathologic features of invasive micropapillary carcinoma

Significance of histopatholoaical evaluation in primary therapy for breast cancer-recent trends in primary modality with pathological complete response(pCR) as endpoint

A case of serum CEA disappearance curve after resection of breast carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer